Catalyst Pharmaceuticals Overview
Catalyst Pharmaceuticals Target Price
Analysts' 12-month price predictions for CPRX.
Share Price
$21.7
Average Target Price
$32.00
47.5% upside
47.5% upside1 analysts in the last 4 months
High: $32 | Low: $32
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-03 | Robert W. Baird | $32 | 47.5% upside |  |
| 2025-02-04 | Robert W. BairdJoel Beatty | $28 | 29% upside | |
| 2025-01-10 | H.C. WainwrightAndrew Fein | $35 | 61.3% upside | |
| 2022-12-21 | Truist Financial | $18 |  17.1% downside | |
| 2022-12-21 | H.C. Wainwright | $24 | 10.6% upside | |
| 2022-12-19 | Piper SandlerJoseph Catanzaro | $20 | 7.8% downside | |
| 2022-08-24 | Roth CapitalScott Henry | $15.5 | 28.6% downside | |
| 2022-08-11 | Truist Financial | $17 | 21.7% downside | |
| 2022-08-11 | H.C. Wainwright | $18 | 17.1% downside | |